Haibo Shao
Haibo Shao
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenocarcinoma, carcinoma, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatocellular carcinoma, liver disorder, metabolic disease, neoplasm | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07557914 | |
| Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not applicable | 2026-05-19 | NCT07594834 |